CE Mark Approval for Sentire® Surgical System Marks New Era for Cornerstone Robotics' Global Expansion

Cornerstone Robotics Expands with CE Approval for Sentire® Surgical System

On May 26, 2026, Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, announced a significant milestone: the CE Mark approval for its Sentire® surgical system. This certification allows the Sentire® system to serve various fields, including general surgery, gynecology, thoracic surgery, and urology throughout Europe.

CE Mark Certification and Its Importance

The CE Mark certification is vital because it verifies that Cornerstone Robotics' system adheres to Europe's stringent regulations for medical devices. This certification not only provides access to European markets but also reassures both physicians and patients about the safety and effectiveness of the innovative technology.

The Sentire® system combines advanced clinical practices with cutting-edge engineering, software, and imaging technologies. This ensures that it meets high standards of safety, efficacy, and quality required by European regulatory authorities. The approval underscores the company’s commitment to clinical excellence and innovation in surgical solutions.

Clinical Trials and Collaborations

Prior to gaining CE certification, Cornerstone Robotics has actively collaborated with Portsmouth Hospitals University NHS Trust in the UK. Since 2025, this partnership has facilitated comprehensive clinical trials to test the Sentire® system in real-world scenarios, gathering data that supports evidence-based research and clinical acceptance.

The Sentire® system has participated in numerous intricate surgical procedures within major specialties, achieving successful results and high satisfaction amongst clinical practitioners. The ongoing real-world clinical trials enable CSR to continuously refine training protocols and operational processes, thus ensuring that medical teams quickly adapt to using the technology proficiently.